Top compounds associated with response to LYZL4


Feature Type Standardized
Nominal ANOVA
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.00072 1
mRNA PD-0332991 GDSC1000 pan-cancer AAC -0.00062 1
mRNA GSK690693 GDSC1000 pan-cancer AAC -0.00051 1
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.00056 1
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC -0.00074 1
mRNA lapatinib UHNBreast pan-cancer AAC 0.0044 1
mRNA BRD-K96431673 CTRPv2 pan-cancer AAC -0.00072 1
mRNA OSI-930 CTRPv2 pan-cancer AAC -0.0003 1
mRNA Dasatinib GDSC1000 pan-cancer AAC 0.0004 1
mRNA CGP-082996 GDSC1000 pan-cancer AAC -0.0004 1
Download CSV